FDA approves first at-home device for depression. What is it?

The FDA has approved Flow Neuroscience's at-home brain stimulation device to treat depression, offering an alternative to ...

FDA approves first new antibiotics to treat gonorrhea in decades, with hope to combat drug resistance

For the first time in decades, the US Food and Drug Administration has signed off on new antibiotics to fight gonorrhea. The ...
MassDevice

FDA approves non-drug, at-home neurostim for treating depression

Flow Neuroscience announced that the FDA approved its Flow at-home brain stimulation device for treating major depressive ...

FDA approves BioCryst's oral pellet version of rare disease drug for children

The U.S. Food and Drug Administration has approved an oral pellet formulation of BioCryst Pharmaceuticals' drug to prevent ...
Fierce Pharma

Italian nonprofit lands FDA approval for 1st gene therapy to treat rare genetic disease

The FDA has issued its stamp of approval to a new, cell-based option to treat Wiskott-Aldrich syndrome (WAS), marking the ...

Milestone Receives FDA Approval of CARDAMYST™ (etripamil) as First and Only Self-Administered Nasal Spray for Adults with Paroxysmal Supraventricular Tachycardia (…

First FDA approved treatment in 30+ years for more than 2 million Americans with PSVT Novel nasal spray designed to rapidly ...

US approves oral drug for adults with rare type of lung cancer after early clinical trials globally

Sevabertinib showed promise in early trials for non-squamous non-small-cell lung cancer with HER2 mutations. Read more at ...
MedPage Today on MSN

FDA Approves New Type of Antibiotic for Gonorrhea, First in Decades

The FDA approved gepotidacin (Blujepa), an oral option for the treatment of uncomplicated urogenital gonorrhea among patients ...

FDA approves cochlear implants for children as young as 7 months

The U.S. Food and Drug Administration has approved an expanded indication for MED-EL (Medical Electronics) cochlear implants ...
ConsumerAffairs

FDA proposes approval of long-sought sunscreen ingredient bemotrizinol

FDA moves to allow a modern sunscreen ingredient widely used outside the U.S. Bemotrizinol offers stronger UVA and UVB ...
Pulmonology Advisor

FDA Drug Approval Decisions Expected in January 2026

The FDA is expected to decide on treatments for breast cancer, EBV+ post-transplant lymphoproliferative disease, focal segmental glomerulosclerosis, presbyopia, and severe allergic reactions.
STAT

FDA approves first new gonorrhea drug in decades

The drug is from a new class of antibiotics, the first new class in decades to be approved as a treatment for gonorrhea, ...